Mini-monovision extends trifocal intraocular lens performance into very near tasks
Bilateral implantation of a trifocal intraocular lens with mini-monovision delivered strong unaided vision across distance, intermediate, and near ranges in this retrospective series, while keeping dysphotopsia and patient dissatisfaction relatively low. The strategy paired a single-piece AcrySof IQ Pan-Optix lens with a modest myopic target in the non-dominant eye, aiming to sharpen functional near vision without sacrificing the broad range of focus expected from a diffractive trifocal design.
The clinical appeal is easy to understand at the bedside. Many patients who choose presbyopia-correcting lenses want more than Snellen acuity; they want to read menus, use phones, and move through the day without glasses. Mini-monovision tries to fill the small gap that standard bilateral trifocal implantation can leave at closer working distances, especially when the patient leans on near tasks more than on intermediate ones.
Visual acuity stayed strong across multiple viewing distances
Thirty-three patients underwent bilateral implantation, with the non-dominant eye targeted to between -0.75 and -1.25 diopters. Mean binocular uncorrected visual acuity reached 20/19 at distance, 20/22 at 60 cm, 20/21 at 40 cm, and 20/28 at 25 cm. Those values point to a lens strategy that preserved distance function while stretching usable vision into the near field rather than forcing a single focal compromise.
The defocus curve was especially important. Binocular visual acuity of 20/25 or better was maintained from -3.50 to +0.50 diopters, a broad functional corridor that suggests useful tolerance for everyday viewing distances and small changes in working distance. Vision loss was limited to one line for all eyes, a reassuring signal in a refractive procedure where even modest decrements can affect patient acceptance.
Stereoacuity remained relatively preserved, with a mean of 88 seconds of arc. In practical terms, that matters because binocular summation and depth perception help patients function in stairs, driving, pouring, and other routine tasks that depend on coordinated visual input rather than acuity alone.
Near vision gained the most from the myopic offset
The strongest signal from this series was the extension of functional near vision. A trifocal platform already distributes light to multiple focal points, but mini-monovision adds a purposeful binocular asymmetry that can sharpen the near endpoint and reduce reliance on reading glasses for close work. In a real-world setting, that can be the difference between acceptable near function and truly independent near function.
The study design did not measure every possible task-based endpoint, yet the pattern of acuity across distance points and the reported defocus range support the idea that the added myopic target broadened the binocular range rather than narrowing it. For patients who value close reading or handheld device use, that extra margin can be clinically meaningful.
Dysphotopsia remained present but generally tolerable
Halos, glare, and starbursts are the tradeoffs that often determine whether a multifocal lens succeeds in daily life. Mean scores for halos, glare, and starbursts were 2.3 ± 1.5, 0.3 ± 1.1, and 0.7 ± 1.4 out of 5, respectively. Those values show that optical phenomena were not absent, but they were not severe enough to blunt overall satisfaction in most patients.
Contrast sensitivity was comparable with prior reports involving the same lens without monovision, suggesting the small myopic offset did not obviously erode image quality. That point is clinically useful because surgeons often worry that adding monovision to a presbyopia-correcting lens will trade away visual quality for range. Here, the balance appears to have stayed reasonably intact.
Satisfaction and spectacle independence were high
Patient-reported outcomes were strong. Mean satisfaction reached 4.3 ± 0.5 out of 5, and 94% of patients reported total spectacle independence. The vision-targeted composite score of the National Eye Institute Visual Function Questionnaire was 95.77 ± 2.14 out of 100, a result that aligns with the acuity data and suggests the binocular strategy translated into day-to-day usability.
A high questionnaire score does not mean every patient was free of visual complaints. It does mean the overall burden of symptoms was low enough, relative to the benefit in daily vision, that most patients judged the outcome favorably. In refractive surgery, that patient-centered balance often matters more than any single optical metric.
Why the binocular approach worked
The logic of this lens strategy rests on binocular engineering. A trifocal optic distributes light for distance, intermediate, and near vision, while the myopic target in the non-dominant eye nudges the system toward a slightly closer focal emphasis. Together, those two elements can smooth the binocular defocus curve and improve the transition into very near distances where standard trifocal correction may soften.
This is not a theoretical nuance. The measured near acuity, the broad defocus performance, and the high rate of spectacle independence all point in the same direction: the added mini-monovision target likely helped fill in the most demanding near segment without causing a major penalty in distance vision or stereopsis.
Practical implications for presbyopia-correcting surgery
For surgeons choosing among presbyopia-correcting options, the study supports mini-monovision as a viable refinement to bilateral trifocal implantation when patients prioritize spectacle freedom. It may be especially attractive for individuals who perform frequent close-range tasks and are comfortable with a small induced anisometropic target in exchange for broader binocular utility.
The data also reinforce the importance of patient selection and counseling. Even with favorable averages, trifocal lenses can still produce halos or other photic phenomena, and the acceptable threshold for those symptoms varies from patient to patient. Preoperative discussion should focus on expected near gains, possible optical side effects, and the fact that the non-dominant eye will be intentionally targeted for mild myopia.
Several limitations remain embedded in the design. This was a retrospective case series with only 33 patients, so the findings cannot establish comparative superiority over bilateral emmetropia, standard trifocal implantation, or other presbyopia-correcting strategies. The cohort size also limits how confidently rare adverse visual experiences can be detected. Even so, the consistency of the acuity, defocus, satisfaction, and spectacle-independence data makes the overall message hard to ignore: in selected patients, bilateral trifocal implantation with mini-monovision can deliver broad functional vision with a high level of patient acceptance.